Emmanuel Gabriel1, Enrique Elli2, Sanjay Bagaria3, Nabil Wasif4, Travis Grotz5, John Stauffer6, Pashtoon M Kasi7, Horacio Asbun6. 1. Department of Surgery, Section of Surgical Oncology, Mayo Clinic Florida, Jacksonville, FL, 32224, USA. Gabriel.Emmanuel@mayo.edu. 2. Department of Surgery, Section of Bariatric Surgery, Mayo Clinic Florida, Jacksonville, FL, 32224, USA. 3. Department of Surgery, Section of Surgical Oncology, Mayo Clinic Florida, Jacksonville, FL, 32224, USA. 4. Department of Surgery, Section of Surgical Oncology, Mayo Clinic Arizona, Phoenix, AZ, 85259, USA. 5. Division of Hepatobiliary Surgery, Department of Surgery, Mayo Clinic, Rochester, MN, 55905, USA. 6. Department of Surgery, Section of Hepatobiliary Surgery, Mayo Clinic Florida, Jacksonville, FL, 32224, USA. 7. Department of Medical Oncology, Mayo Clinic Florida, Jacksonville, FL, 32224, USA.
Abstract
BACKGROUND: Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) is an appropriate treatment for select patients with peritoneal carcinomatosis. While most commonly performed through an open incision, the laparoscopic approach has been reported and offers short-term benefits. A robotic-assisted approach for carcinomatosis of gastrointestinal origin, however, has not yet been described. METHODS: We report our approach to robotic-assisted CRS-HIPEC for a patient with a perforated appendiceal mucocele. Our dynamic video highlights the advantages of this approach. RESULTS: Our patient was a 57-year-old woman with minimal residual disseminated peritoneal adenomucinosis (DPAM), having a peritoneal carcinomatosis index (PCI) score of 1. She had a previous surgical history of a Roux-en-Y gastric bypass. A robotic-assisted approach was utilized using the Intuitive daVinci Xi robotic surgical system through 4 ports. No laparoscopic assistant port was required. The operative time was 426 min, and the estimated blood loss was 50 cc. The greater omentum, falciform ligament, bilateral ovaries, and two small areas of tumor implant were resected. The post-operative length of stay was 4 days, and the patient had regained bowel function by post-operative day 2. CONCLUSIONS: Our video demonstrates the feasibility of a robotic-assisted CRS-HIPEC in a patient with minimal, residual DPAM. Similar to a laparoscopic approach, the short-term outcomes are improved as compared to an open approach. An MIS approach to CRS-HIPEC, now with the first-reported robotic-assisted approach, is a viable option for select patients with peritoneal tumors.
BACKGROUND: Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) is an appropriate treatment for select patients with peritoneal carcinomatosis. While most commonly performed through an open incision, the laparoscopic approach has been reported and offers short-term benefits. A robotic-assisted approach for carcinomatosis of gastrointestinal origin, however, has not yet been described. METHODS: We report our approach to robotic-assisted CRS-HIPEC for a patient with a perforated appendiceal mucocele. Our dynamic video highlights the advantages of this approach. RESULTS: Our patient was a 57-year-old woman with minimal residual disseminated peritoneal adenomucinosis (DPAM), having a peritoneal carcinomatosis index (PCI) score of 1. She had a previous surgical history of a Roux-en-Y gastric bypass. A robotic-assisted approach was utilized using the Intuitive daVinci Xi robotic surgical system through 4 ports. No laparoscopic assistant port was required. The operative time was 426 min, and the estimated blood loss was 50 cc. The greater omentum, falciform ligament, bilateral ovaries, and two small areas of tumor implant were resected. The post-operative length of stay was 4 days, and the patient had regained bowel function by post-operative day 2. CONCLUSIONS: Our video demonstrates the feasibility of a robotic-assisted CRS-HIPEC in a patient with minimal, residual DPAM. Similar to a laparoscopic approach, the short-term outcomes are improved as compared to an open approach. An MIS approach to CRS-HIPEC, now with the first-reported robotic-assisted approach, is a viable option for select patients with peritoneal tumors.
Authors: J Esquivel; R Sticca; P Sugarbaker; E Levine; T D Yan; R Alexander; D Baratti; D Bartlett; R Barone; P Barrios; S Bieligk; P Bretcha-Boix; C K Chang; F Chu; Q Chu; S Daniel; E de Bree; M Deraco; L Dominguez-Parra; D Elias; R Flynn; J Foster; A Garofalo; F N Gilly; O Glehen; A Gomez-Portilla; L Gonzalez-Bayon; S Gonzalez-Moreno; M Goodman; V Gushchin; N Hanna; J Hartmann; L Harrison; R Hoefer; J Kane; D Kecmanovic; S Kelley; J Kuhn; J Lamont; J Lange; B Li; B Loggie; H Mahteme; G Mann; R Martin; R A Misih; B Moran; D Morris; L Onate-Ocana; N Petrelli; G Philippe; J Pingpank; A Pitroff; P Piso; M Quinones; L Riley; L Rutstein; S Saha; S Alrawi; A Sardi; S Schneebaum; P Shen; D Shibata; J Spellman; A Stojadinovic; J Stewart; J Torres-Melero; T Tuttle; V Verwaal; J Villar; N Wilkinson; R Younan; H Zeh; F Zoetmulder; G Sebbag Journal: Ann Surg Oncol Date: 2006-10-28 Impact factor: 5.344
Authors: Olivier Glehen; François N Gilly; Florent Boutitie; Jean M Bereder; François Quenet; Lucas Sideris; Baudouin Mansvelt; Gérard Lorimier; Simon Msika; Dominique Elias Journal: Cancer Date: 2010-08-24 Impact factor: 6.860
Authors: Anna Fagotti; Barbara Costantini; Valerio Gallotta; Stefano Cianci; Carlo Ronsini; Marco Petrillo; Mara Pacciani; Giovanni Scambia; Francesco Fanfani Journal: J Minim Invasive Gynecol Date: 2014-11-26 Impact factor: 4.137
Authors: Edward A Levine; Konstantinos I Votanopoulos; Perry Shen; Greg Russell; Joyce Fenstermaker; Paul Mansfield; David Bartlett; John H Stewart Journal: J Am Coll Surg Date: 2018-01-10 Impact factor: 6.113
Authors: Boateng Kubi; Richard Nudotor; Nadege Fackche; Wasay Nizam; Jordan M Cloyd; Travis E Grotz; Keith F Fournier; Sean P Dineen; Benjamin D Powers; Jula Veerapong; Joel M Baumgartner; Callisia N Clarke; Sameer H Patel; Laura A Lambert; Daniel E Abbott; Kara A Vande Walle; Mustafa Raoof; Byrne Lee; Shishir K Maithel; Charles A Staley; Fabian M Johnston; Jonathan B Greer Journal: Ann Surg Oncol Date: 2021-01-28 Impact factor: 5.344
Authors: Turki Alshammari; Sulaiman Alshammari; Riyadh Hakami; Abdullah Alharbi; Mohammad Alyami; Maha Abdulla; Thamer Bin Traiki Journal: Am J Case Rep Date: 2019-11-09
Authors: Emmanuel M Gabriel; Minhyung Kim; Daniel T Fisher; Catherine Mangum; Kristopher Attwood; Wenyan Ji; Debabrata Mukhopadhyay; Sanjay P Bagaria; Matthew W Robertson; Tri A Dinh; Keith L Knutson; Joseph J Skitzki; Michael B Wallace Journal: Sci Rep Date: 2021-03-02 Impact factor: 4.379